鲁欣然,赖雪峰,孙凤,詹思延,王胜锋.加强药物基因组学研究报告规范(STROPS)及解读[J].中华流行病学杂志,2022,43(5):747-754 |
加强药物基因组学研究报告规范(STROPS)及解读 |
Strengthening the Reporting of Pharmacogenetic Studies (STROPS) guideline |
收稿日期:2021-04-02 出版日期:2022-05-13 |
DOI:10.3760/cma.j.cn112338-20210402-00276 |
中文关键词: 药物基因组学研究报告规范 条目清单 解读 |
英文关键词: Strengthening the Reporting of Pharmacogenetic Studies Guideline Checklist Interpretation |
基金项目:国家自然科学基金(81502884);国家重点研发计划(2018YFC1311704) |
|
摘要点击次数: 2977 |
全文下载次数: 1062 |
中文摘要: |
药物基因组学研究旨在探究遗传变异与药物的疗效和不良反应之间的关联,对样本量有很高的要求。为有效进行Meta分析以探究药物遗传关联,亟需提高药物基因组学研究报告质量。2020年制定的加强药物基因组学研究报告规范(Strengthening the Reporting of Pharmacogenetic Studies,STROPS)在STREGA规范(Strengthening the Reporting of Genetic Association Studies)的基础上进行补充和修改,为药物基因组学研究报告提供专门的指导。本文将重点介绍STROPS并对部分条目进行解读,同时给出实例以便理解和应用。 |
英文摘要: |
Pharmacogenetic studies are designed to investigate the associations between genetic variation and treatment response for a particular drug in terms of both efficacy and adverse events and have high sample size requirements. To improve the quality of pharmacogenetic studies and facilitate the Meta-analyses to investigate statistically significant associations, Strengthening the Reporting of Pharmacogenetic Studies (STROPS) guideline was developed in 2020 based on the Strengthening the Reporting of Genetic Association Studies (STREGA) statement. The objective of this article is to present a brief introduction to the STROPS guideline and an interpretation of the key points in some items with examples for the better understanding and application. |
查看全文
Html全文
查看/发表评论 下载PDF阅读器 |
|
关闭 |